Latest News
-
In Settling Fraud Case, New York Medicare Advantage Insurer, CEO Will Pay up to $100M
-
Readers Offer ‘Solo Agers’ Support and Reflect on Ancestors
-
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
-
Employers Press Congress To Cement Health Price Transparency Before Trump’s Return
-
What’s Next for State Abortion Ballot Initiatives?
Following the passage of abortion rights measures in some states, we examine what’s ahead for state abortion ballot initiatives and restrictions — including how 2024 abortion initiatives may affect states that didn’t previously have bans.
-
Myths About Raw Milk and Vaccines
This week’s Health Misinformation Monitor explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It also examines how trust and perceived expertise influence misinformation and AI’s role in spreading false mental health information.
-
Medicare Negotiated Drug Prices Are Higher Than Peer Nations
Our analysis finds that Medicare’s negotiated prices for 10 high-expenditure prescription drugs are lower than what private Medicare drug plans had been paying, but still much higher than the prices available in 11 other wealthy nations.
-
Beyond the Data, a Column by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.